Treatment of extensive small cell lung cancer with carboplatin and teniposide
- 30 September 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (9) , 1109-1112
- https://doi.org/10.1016/0277-5379(91)90304-v
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials GroupBritish Journal of Cancer, 1988
- Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.Journal of Clinical Oncology, 1987
- Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.Journal of Clinical Oncology, 1987
- VP-16 and cisplatin as first-line therapy for small-cell lung cancer.Journal of Clinical Oncology, 1985
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982